BDNF and Alzheimer disease: Cocaine- and amphetamine-related transcript peptide (CART) and brain-derived neurotrophic factor (BDNF) can be also released from LC neurons [173]; these substances emerge as useful targets in AD therapy due to their role in anti-inflammatory [176] and neurotrophic signaling [177], respectively.